Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30.2M
-
Number of holders
-
182
-
Total 13F shares, excl. options
-
16.1M
-
Shares change
-
+776K
-
Total reported value, excl. options
-
$350M
-
Value change
-
+$18.5M
-
Put/Call ratio
-
0.01
-
Number of buys
-
75
-
Number of sells
-
-81
-
Price
-
$21.73
Significant Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q3 2024
214 filings reported holding FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) has 182 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.1M shares
of 30.2M outstanding shares and own 53.27% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (3.92M shares), VANGUARD GROUP INC (1.45M shares), MILLENNIUM MANAGEMENT LLC (1.27M shares), DIMENSIONAL FUND ADVISORS LP (1.11M shares), STATE STREET CORP (794K shares), Park West Asset Management LLC (714K shares), GEODE CAPITAL MANAGEMENT, LLC (503K shares), MORGAN STANLEY (467K shares), AMERIPRISE FINANCIAL INC (356K shares), and JPMORGAN CHASE & CO (338K shares).
This table shows the top 182 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.